Call us toll free: +(9122) 4919 8700

Cancer

KRISHGEN has developed an extensive range of assays specifically targeting cancer / oncology research and therapeutics. Our assays are available for the biomarkers and the therapeutic monoclonal antibody or small molecule developed for these markers. We also offer a wide portfolio of immunogenicity assays for these drugs.

This page is being continously updated with more products. If you require a specific assay, please contact us and we will be happy share details with you.

View specific ELISA available for drugs targeting treatment of:

Drug Targets for Breast Cancer

Drug TargetsCancer DrugsBiomarker AssayKRISHGEN Assay
HER2Trastuzumab Human HER2 ELISATrastuzumab ELISA
TigatuzumabTigatuzumab ELISA
MargetuximabMargetuximab ELISA
PertuzumabPertuzumab ELISA
Trastuzumab emtansineTrastuzumab emtansine ELISA
Trastuzumab deruxtecan
Lapatinib
CDK4 / CDK6PalbociclibHuman CDK4 ELISA
mTOREverolimusHuman mTOR ELISAEverolimus ELISA
VEGF-ABevacizumabHuman VEGF-A ELISABevacizumab ELISA
HER3ElgemtumabHuman HER3 ELISAElgemtumab ELISA
Patritumab DeruxtecanPatritumab Deruxtecan ELISA
PD-L1AtezolizumabHuman PD-L1 ELISAAtezolizumab ELISA
CD20TositumomabHuman CD20 ELISA
CD79BPolatuzumab vedotinHuman B-Cell Antigen Receptor complex-associated Protein beta Chain (CD79B) ELISAPolatuzumab vedotin ELISA
CD19Denintuzumab mafodotinHuman CD19 ELISADenintuzumab mafodotin ELISA
CD22EpratuzumabHuman CD22 ELISAEpratuzumab ELISA
CD20xCD3 bsAbMosunetuzumabHuman CD20 ELISA / Human CD3 ELISAMosunetuzumab ELISA
TNF AlphaEtanerceptHuman TNF Alpha ELISAEtanercept ELISA
Complement C5EculizumabHuman C5 ELISAEculizumab ELISA
RANKLDenosumabHuman RANKL ELISADenosumab ELISA
SamrotamabSamrotamab ELISA
TauSemorinemabTau Proteins ELISASemorinemab ELISA
IL-6SirukumabHuman Interleukin 6 (IL-6 / IL6) ELISASirukumab ELISA
ERBB2TimigutuzumabHuman Receptor Tyrosine Protein Kinase Erbb-2 (ERBB2) ELISATimigutuzumab ELISA
ICOSVopratelimabHuman Inducible T-Cell Co Stimulator (ICOS) ELISAVopratelimab ELISA
IGF1 / IGF2XentuzumabHuman Insulin Like Growth Factor 1 (IGF1) ELISA / Human Insulin Like Growth Factor 2 (IGF2) ELISAXentuzumab ELISA
HER2/HER2 bsABZanidatamabHuman HER2 ELISAZanidatamab ELISA
CD105CarotuximabHuman CD105 ELISACarotuximab ELISA
Cofetuzumab PelidotinCofetuzumab Pelidotin ELISA
PD-1DostarlimabHuman PD-1 ELISADostarlimab ELISA
CSF-1LacnotuzumabLacnotuzumab ELISA
Ladiratuzumab VedotinLadiratuzumab Vedotin ELISA
B7H3MirzotamabHuman Cluster Of Differentiation 276 (CD276) ELISAMirzotamab ELISA
VEGFOlinvacimabHuman Vascular Endothelial Cell Growth Factor (VEGF) ELISAOlinvacimab ELISA
IGF-1RDalotuzumabHuman Insulin Like Growth Factor 1 Receptor (IGF1R) ELISADalotuzumab ELISA
LINGO1OpicinumabHuman Leucine-Rich Repeat And Immunoglobulin-Like Domain-Containing Nogo Receptor-Interacting Protein 1 (LINGO1) ELISAOpicinumab ELISA
DLL4 / VEGF bsABNavicixizumabNavicixizumab ELISA
CEA / CD3 bsAbCibisatamabHuman carcinoembryonic Antigen ELISA / Human CD3 ELISACibisatamab ELISA
EGFL-7ParsatuzumabHuman EGF-Like Domain Protein Multiple 7 (EGFL7) ELISAParsatuzumab ELISA

Drug Targets for Bladder Cancer

Drug Targets for Bone Marrow Cancer

Drug Targets for Cervical Cancer

Drug Targets for Colorectal Cancer

Drug Targets for Head and Neck Cancer

Drug Targets for Leukemia

Drug Targets for Liver Cancer

Drug Targets for Lung Cancer

Drug Targets for Lymphoma

Drug Targets for Oesophageal Cancer 

Drug Targets for Ovarian Cancer

Drug Targets for Prostate Cancer

Drug Targets for Renal Cancer

Drug Targets for Stomach / Gastro-Intestinal Cancer

Contact Tech Support

CAN’T FIND WHAT YOU’RE LOOKING FOR? Get in touch with our technical team for support.